Crescent Biopharma, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2012 | $-10.5M | $-10.8M | $316.2K | — |
| FY2013 | $-15.5M | $-15.6M | $82.1K | — |
| FY2014 | $-4.3M | $-4.5M | $212.6K | $1.6M |
| FY2015 | $-8.2M | $-8.5M | $268.6K | $2.3M |
| FY2016 | $-29.7M | $-30.4M | $704.2K | $3.0M |
| FY2017 | $-29.8M | $-30.1M | $294.1K | $3.8M |
| FY2018 | $-43.3M | $-43.5M | $125.6K | $4.6M |
| FY2019 | $-52.0M | $-52.1M | $144.9K | $6.2M |
| FY2020 | $-39.2M | $-39.3M | $68.5K | $6.9M |
| FY2021 | $-57.5M | $-57.5M | $14.9K | $6.1M |
| FY2022 | $-46.5M | $-46.5M | $84.2K | $3.9M |
| FY2023 | $-34.9M | $-34.9M | $21.4K | $3.5M |
| FY2024 | $-31.1M | $-31.1M | $10.0K | $4.7M |
| FY2025 | $-71.5M | $-72.5M | $919.0K | $13.3M |